Once-daily dosing that allows patients to start at the effective dose1

  • Titration-free1
  • Once-daily1
  • Taken orally with or without food1

See full Prescribing Information for dosing in patients with moderate or severe hepatic impairment or concomitant use with CYP3A4 inhibitors or inducers.

Frequently asked questions about dosing

References: 1. Data on File. Study ITI-007-301 Clinical Study Report. Intra-Cellular Therapies; 2016. 2. Data on File. Integrated Summary of Safety. Intra-Cellular Therapies; 2019. 3. CAPLYTA full prescribing information, 2022. 4. Stroup TS, Marder S. Pharmacotherapy for schizophrenia: acute and maintenance phase treatment. UpToDate. Updated April 21, 2020. Accessed May 17, 2022.